Astec LifeSciences Confirms No Undisclosed Price-Sensitive Developments

• Astec LifeSciences responds to NSE query on recent stock price movement.
• Company confirms full compliance with SEBI Listing and PIT Regulations.
• Asserts no undisclosed developments requiring mandatory disclosure exist.
• Reaffirms commitment to timely disclosures under applicable regulations.